| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |